SpyGlass Pharma, Inc.
SGP
$27.50
-$1.42-4.91%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
9/2/2026
-
Globe Newswire
9/1/2026
-
MarketBeat
8/15/2026
-
MarketBeat
8/14/2026
-
24/7 Wall St.
8/11/2026
-
The Cerbat Gem
8/11/2026
-
MarketBeat
8/8/2026
-
MarketBeat
8/7/2026
-
Seeking Alpha - Healthcare
8/6/2026
-
TipRanks: TheFly
8/6/2026
-
Nasdaq News: Markets
8/6/2026
-
Globe Newswire
8/5/2026
-
The Cerbat Gem
8/5/2026
-
Simply Wall St
8/4/2026
-
The Cerbat Gem
8/4/2026
-
The Cerbat Gem
7/28/2026
-
The Cerbat Gem
7/24/2026
-
MarketBeat
7/15/2026
-
The Cerbat Gem
7/15/2026
-
The Cerbat Gem
7/14/2026
-
The Cerbat Gem
7/13/2026
-
MarketBeat
6/29/2026
-
The Cerbat Gem
6/26/2026
-
The Cerbat Gem
6/15/2026
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, August 6, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Mar 22 and 26 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
949 284 6904
Address
15326 Alton Parkway
Irvine, CA 92618
Irvine, CA 92618
Country
Year Founded
Business Description
Sector
SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug...
more